flow trial semaglutide kidney outcomes nejm 2024 hazard ratio Long-term of in obesity and cardiovascular disease in the SELECT Effects of semaglutide FLOWing with the SemagluTIDE —

Some supplements can result in a higher heart rate

This is also why Chris often recommends lab work and genetic testing

With oral sema removing the needle barrier, these numbers could multiply, and by the time Lilly mobilizes their own D2C channels, patients will already be stable on sema and we know that switching stable patients is very difficult

Clinical trials have followed patients for multiple years without identifying new safety concerns that emerge with longer use

It is also banned by WADA (World Anti-Doping Agency) and ASADA, so competitive athletes can (and have) received bans for using it

The useful conversation with a provider is about which option suits your clinical profile and goals, with price treated as one input rather than the answer